Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01760226 Background | Jan 2013 → Aug 2016 | post-transplant lymphoproliferative disease, primary mediastinal large B-cell lymphoma | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01760226 ↗ |
| Route | Subcutaneous | “G-CSF 5mcg/kg/day will be given under the skin” NCT01760226 ↗ |